Clarity Pharmaceuticals Ltd (CU6) Stock Price, News, Quotes-Moomoo

AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist

5.680
-0.290-4.86%

20min DelayMarket Closed Nov 22 16:00 AET

1.82BMarket Cap-36645P/E (Static)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Clarity Pharmaceuticals Reports Successful AGM Resolutions
TipRanksNov 19 22:09 ET
Clarity Pharmaceuticals Signs Supply Deal for Prostate Cancer Drug; Shares Up 3%
MT NewswiresNov 10 22:05 ET
Clarity Pharmaceuticals Says US Health Agency Publishes New Policy on Radio-diagnostics Reimbursement
MT NewswiresNov 4 21:13 ET
Clarity Pharmaceuticals Ltd's (ASX:CU6) Top Owners Are Individual Investors With 58% Stake, While 18% Is Held by Insiders
Yahoo FinanceOct 30 17:06 ET
Clarity Pharmaceuticals Expands Market Presence With New Share Issue
TipRanksOct 28 01:37 ET
Clarity Pharmaceuticals Sets Date for 2024 AGM
TipRanksOct 17 21:37 ET

Comments

Sanjeev Kaushik

Jul 17 01:02

General Recommendation: Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd (ASX: CU6)
Target: 7.04
Stop Loss: 4.3
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Note: The closing must be tracked on weekly basis i.e you should exit the ...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CU6 Clarity Pharmaceuticals Ltd

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target